20
Sanofi Winthrop Industrie Gentilly Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Trimipramine maleate, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2003-121 - Rev 04
This Chemical Type CEP, issued on February 02, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 534 associated with this CEP further emphasizes